4//SEC Filing
Aralez Pharmaceuticals Inc. 4
Accession 0001104659-16-128428
CIK 0001660719operating
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 9:25 PM ET
Size
7.7 KB
Accession
0001104659-16-128428
Insider Transaction Report
Form 4
Fowler Neal Franklin
Director
Transactions
- Award
Employee Stock Option (right to buy)
2016-06-16+15,000→ 15,000 totalExercise: $3.42Exp: 2026-06-16→ Common Shares, without par value (15,000 underlying) - Award
Common Shares, without par value
2016-06-16+7,500→ 66,369 total
Footnotes (3)
- [F1]Restricted Stock Units, all of which vest on the earlier of June 16, 2017 or the date of the Company's next annual shareholder meeting, subject to the director's continued service on the Board as of such date. Vested shares will be delivered to the Reporting Person on the earlier of the date that the Reporting Person ceases to provide services to the Board and the date of a Change of Control, as defined in the Issuer's 2016 Long-Term Incentive Plan, in either case provided that the Restricted Stock Units are vested on such date.
- [F2]Includes 58,869 shares of Common Stock and 7,500 Restricted Stock Units.
- [F3]The option vests in one installment on the earlier of June 16, 2017 or the date of the Company's next annual shareholder meeting, subject to the director's continued service on the Board as of such date.
Documents
Issuer
Aralez Pharmaceuticals Inc.
CIK 0001660719
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001660719
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 9:25 PM ET
- Size
- 7.7 KB